PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents

CompletedOBSERVATIONAL
Enrollment

893

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

March 29, 2024

Study Completion Date

March 29, 2024

Conditions
Acute Pancreatitis
Interventions
DRUG

Proton pump inhibitor

Patients who received a lumen apposing metal stent (LAMS) for drainage of a walled off necrosis (WON) upon acute pancreatitis will be divided into a PPI/Non-PPI group depending on if they concomitantly were prescribed a PPI or not

DEVICE

LAMS-implantation

Patients who received a lumen apposing metal stent (LAMS) for drainage of a walled off necrosis (WON) upon acute pancreatitis

Trial Locations (1)

37075

University Medical Center Goettingen, Goettigen

All Listed Sponsors
collaborator

Technical University of Munich

OTHER

collaborator

Ludwig-Maximilians - University of Munich

OTHER

collaborator

University Hospital in Halle

OTHER

collaborator

University of Leipzig

OTHER

collaborator

University Hospital Heidelberg

OTHER

collaborator

Landesklinikum Sankt Polten

OTHER

collaborator

University Hospital, Aachen

OTHER

collaborator

University of Oldenburg

OTHER

collaborator

University of Newcastle Upon-Tyne

OTHER

collaborator

Szeged University

OTHER

collaborator

University of Pecs

OTHER

collaborator

Semmelweis University

OTHER

collaborator

University of Ulm

OTHER

collaborator

University Hospital Olomouc

OTHER

collaborator

Brno University Hospital

OTHER

collaborator

University Hospital Regensburg

OTHER

collaborator

Klinikum Stadt Hanau

OTHER

collaborator

University Medicine Greifswald

OTHER

lead

University Medical Center Goettingen

OTHER

NCT05817721 - PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents | Biotech Hunter | Biotech Hunter